Authors
Latest:
The Potential Impacts of Targeted Drug Advertising on Social MediaIn part 2 of our video series with drug market experts Luke Turnock, PhD, and Jenny Markell, we explored social media advertisements for prescription drugs and how they may impact patients.
Latest:
When Molecular Testing is Superior to Antigen Testing for Infectious DiseasesProviding people with the ability to test for viruses in their own homes empowers them to be proactive about their health while helping public health officials, policymakers, and researchers with information that could head off the next pandemic.
Latest:
Quizartinib Approved for Newly Diagnosed AML in Patients with ITDOverall median survival was higher in participants taking quizartinib, according to results from QuANTUM-First trial.
Latest:
Three Small Staffing Changes That Can Boost Your Pharmacy's ProfitsAlthough there's no magic formula for finding the appropriate pharmacy staffing levels, there are subtle shifts you can make that will have a big impact on your bottom line.
Latest:
FDA Approves Voquezna for Helicobacter pylori Infection in AdultsThis new treatment option copackages 3 drugs for optimal treatment.
Latest:
TICOVAC Vaccine to Prevent Tick-Borne EncephalitisThe FDA approved a biologics license application for the tick-borne encephalitis (TBE) vaccine TICOVAC for individuals 1 year or older.
Latest:
Pharmacy Technicians on the Front Line of Health CareThe need for skilled and knowledgeable pharmacy technicians in our workforce remains steady throughout current times.
Latest:
The Evolution of PharmacogenomicsPharmacogenomics provides an opportunity for pharmacists to enhance their role in patient care.
Latest:
ASHP’s Outlook for the Pharmacy Profession in 2025Joseph DiPiro, PharmD, FCCP, FAAAS, broke down the importance of the ASHP Pharmacy Forecast and the process in which its content is curated.
Latest:
OTC Medications to Treat the Young AthleteA variety of nonprescription treatments, supplements, and patches can alleviate pain for children and adolescents.
Latest:
Pharmacy Law Lowdown: PBM Audit Trends, Enforcement ActionsDae Lee, PharmD, Esq, CPBS and Lucas Morgan, Esq, discuss PBM and board of pharmacy enforcement actions, trends in PBM audits, and more.
Latest:
Patient Treatment Costs to rise 7% in 2024, Report FindsThe increase is expected to be somewhat offset by the impact of biosimilars coming to market and more care being provided in outpatient settings.
Latest:
How Can Improving Provider-Patient Relationships Help Reverse Chronic Disease?The existing approach to disease management may be ill-suited to address the dynamic and diverse factors at play when it comes to chronic illness.
Latest:
In July, PBMs Found Themselves in the Federal Government Hot SeatAn interim FTC report outlined how the rise of vertical integration and concentration has led to devastating results for both patients and fragile pieces of the health care delivery system.
Latest:
Elranatamab-bcmm Approved for Adult Patients With Relapsed or Refractory Multiple MyelomaThe novel drug elranatamab-bcmm (Elrexfio) received accelerated FDA approval on August 14, 2023, for treating adults with relapsed or refractory multiple myeloma.
Latest:
Pembrolizumab Approved in China for Frontline Advanced Esophageal CancerThe National Medical Products Administration in China has approved pembrolizumab for use in combination with platinum and fluoropyrimidine-based chemotherapy for the frontline treatment of patients.
Latest:
Important Updates in RSV Vaccination Guidelines | ASHP MidyearA conversation with Chelsea Keedy, PharmD, BCACP, clinical assistant professor at the University of Georgia, on RSV vaccine recommendations.
Latest:
What Does the Future of Pain Medicine Look Like?With minimal pharmacological treatments coming to market for chronic pain, researchers have explored new technologies for advancing pain treatment across the globe.
Latest:
Study: Biologic Therapies Improve Clinical Outcomes in Patients With Severe AsthmaImprovement across all asthma control parameters was achieved after 12 months of biologic treatment with mepolizumab, benralizumab, and omalizumab.
Latest:
The Role of Complementary and Alternative Medicine in PharmacyIt’s crucial to be openminded about these approaches, and to convey accurate information to patients in a nonjudgmental manner.
Latest:
Q&A: How Technician Fatigue Threatens Patient Safety, CareTaylor Watterson, PharmD, PhD, discusses how pharmacy technician burnout can impact pharmacy operations.
Latest:
Q&A: Pharmacist Prescribed Contraception Can Mitigate Barriers to CareA conversation with Ginger Lemay, PharmD, Jeffrey Bratberg, PharmD, and Audrey Whalen, PharmD.
Latest:
Data, Collaboration Can Help Unlock the Full Potential of Value-Based CareA unified data ecosystem will provide the foundation for the next generation of patient-care technology.
Latest:
How to Help Make Health Equity a RealityCMS and state officials are using payment incentives, data collection and program requirements to start edging the lofty ideals of health equity toward reality.
Latest:
The Regimen: Portrayal of Pharmacists in MediaJeffrey Bratberg, PharmD and Madi Hartling, a 2025 PharmD candidate, discuss the lack of pharmacists in medical shows and how pharmacists are typically portrayed negatively in media.
Latest:
Two-Dose HepB Vaccine Not Associated With Increased Risk of Acute MIThe 2-dose hepatitis B vaccine was not associated with a higher risk of acute myocardial infarction compared with the 3-dose hepatitis B vaccine series.
Latest:
Examining the State of Benzoyl Peroxide-Containing Acne Products After Benzene ContaminationChristopher Bunick, MD, PhD, FAAD, an associate professor of dermatology and a physician-scientist at the Yale School of Medicine in New Haven, Connecticut, presented updates on benzene in BPO at the 2024 American Academy of Dermatology Annual Meeting.
Latest:
Barhemsys (Amisulpride) for Postoperative Nausea and VomitingOn February 27, 2020, the FDA approved an intravenous solution of amisulpride (Barhemsys; Acacia Pharma) to treat and prevent postoperative nausea and vomiting.
Latest:
COPD Exacerbations Reduced Substantially With Dupilumab, Phase 3 Data ShowsThe NOTUS trial was shown to have successfully achieved its primary endpoint, demonstrating the notable efficacy of dupilumab in reducing exacerbations by 34% versus placebo in individuals with moderate-to-severe COPD showing evidence of type 2 inflammation.
Latest:
A Surge in Mpox Cases Could Occur This SummerDemetre Daskalakis, MD, MPH, urged those in the LGBTQ+ community to get fully vaccinated against the disease.
